Mette Ilander
Impact in
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- interferon and immune responses
Papers in
- Immunology 14
- Immune Cell Function and Interaction 10
- Immunotherapy and Immune Responses 6
- Oncology 12
- CAR-T cell therapy research 8
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Satu Mustjoki (23 shared papers)Anna Kreutzman (11 shared papers)Kimmo Porkka (5 shared papers)Can Hekim (2 shared papers)Jukka Vakkila (2 shared papers)Oscar Brück (8 shared papers)Olli Dufva (6 shared papers)Katariina Hannula‐Jouppi (3 shared papers)
In The Last Decade
Mette Ilander
25 papers receiving 466 citations
Peers
Comparison fields: 5 of 54
- Hematology 137
- Immunology 225
- Genetics 70
- Oncology 143
- Rheumatology 39
Countries citing papers authored by Mette Ilander
This map shows the geographic impact of Mette Ilander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mette Ilander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mette Ilander more than expected).
Fields of papers citing papers by Mette Ilander
This network shows the impact of papers produced by Mette Ilander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mette Ilander. The network helps show where Mette Ilander may publish in the future.
Co-authors
The 25 scholars most cited alongside Mette Ilander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 65 | |
| 2 | 2020 | 47 | |
| 3 | 2019 | 46 | |
| 4 | 2017 | 38 | |
| 5 | 2014 | 35 | |
| 6 | 2017 | 34 | |
| 7 | 2014 | 28 | |
| 8 | 2016 | 27 | |
| 9 | 2014 | 26 | |
| 10 | 2018 | 22 | |
| 11 | 2023 | 19 | |
| 12 | 2020 | 17 | |
| 13 | 2011 | 17 | |
| 14 | 2021 | 16 | |
| 15 | 2020 | 6 | |
| 16 | 2014 | 6 | |
| 17 | 2023 | 5 | |
| 18 | 2019 | 3 | |
| 19 | 2019 | 3 | |
| 20 | 2018 | 3 |
About Mette Ilander
Mette Ilander is a scholar working on Immunology, Oncology, Hematology, Genetics and Molecular Biology, having authored 25 papers that have together received 469 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (10 papers), Chronic Myeloid Leukemia Treatments (8 papers), Chronic Lymphocytic Leukemia Research (8 papers), CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Eosinophilic Disorders and Syndromes (3 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (137 citations), Immunology (225 citations), Genetics (70 citations), Oncology (143 citations) and Rheumatology (39 citations). Mette Ilander has collaborated with scholars based in Finland, Sweden and Norway. Frequent co-authors include Satu Mustjoki, Anna Kreutzman, Kimmo Porkka, Can Hekim, Jukka Vakkila, Oscar Brück, Olli Dufva, Katariina Hannula‐Jouppi, Micaela Hernberg and Panu E. Kovanen. Their work appears in journals such as Cancer Immunology Research, Blood, PLoS ONE, OncoImmunology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.